DOI:
10.1055/s-00000012
Endoscopy
LinksClose Window
References
Noordman BJ, Shapiro J, Spaander MC. et al.
Accuracy of detecting residual disease after Cross neoadjuvant chemoradiotherapy for esophageal cancer (preSANO Trial): rationale and protocol.
JMIR Res Protoc 2015;
4: e79
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.